ClinicalTrials.gg
Sign In
TerminatedNCT01654406Updated Jul 13, 2016

Fractional CO2 Laser in the Treatment for Cesarian Scar

An interventional study of Fractional CO2 laser and pulsed dye laser and Pulsed dye laser in Cesarian Scar, sponsored by Taipei Medical University WanFang Hospital. Terminated at 1 site in Taiwan. Open to female participants. Per ClinicalTrials.gov, last updated 2016-07-13.

Sponsored by Taipei Medical University WanFang Hospital · Not applicable, Interventional, and Treatment

Why this study was terminated
because 1 patient's scar becomes more severe than before, and most patient have satificated outcome
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Sex
Female
01

Study summary

Fractional CO2 laser can improve the Cesarian scar

02

Conditions studied

  • Cesarian Scar

Keywords

  • Cesarian scar
  • Fractional CO2 laser
03

In context

Lead sponsor

Taipei Medical University WanFang Hospital is the lead sponsor of 200 studies on the registry; 19 are open to participants now.

Browse Taipei Medical University WanFang Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female receiving Cesarean surgery for more than 1 month

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Keloid
  • Photosensitivity
  • Wound
  • Pacemaker
  • Recent retinoid intake
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
8 participants (actual)

Study arms

  • Active comparator
    Control

    Pulsed dye laser (V-beam)

    Device: Pulsed dye laser

  • Experimental
    Experimental group

    Fractional CO2 laser(eCO2)and pulsed dye laser (V-beam)

    Device: Fractional CO2 laser and pulsed dye laser

Interventions

  • DeviceFractional CO2 laser and pulsed dye laser

    Fractional CO2 laser: 50 mJ, 100 spots/cm2, a scan area of 4\_4mm, static mode, and two passes Pulsed dye laser: 5mm,1.5ms,8J,delay cooling device 30/30,one pass

  • DevicePulsed dye laser

    Pulsed dye laser: 5mm,1.5ms,8J,delay cooling device 30/30,one pass

06

What researchers measure

Primary outcomes

  1. change of Vancouver Scar Scale (VSS)

    We measured quartile grading scale at 1st, 5th and 7th months of study and evaluated the change of the scale

    Time frame: 1st, 5th, 7th month

Secondary outcomes

  1. Quartile grading scale

    We measured quartile grading scale at 5th and 7th months of study.

    Time frame: 5th, 7th month

07

Study locations

1 site
  • Wan Fang Hospital
    Taipei, Taiwan 116, Taiwan
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2012, a primary completion of Jan 2013 and a completion of Jan 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2012
First posted
Jul 31, 2012
Start
Jul 2012
Primary completionActual
Jan 2013
CompletionActual
Jan 2013
Last update
Jul 13, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01654406
Lead sponsor
Taipei Medical University WanFang Hospital
Responsible party
Sponsor
First posted
Jul 31, 2012
Start date
Jul 2012
Primary completion
Jan 2013
Completion
Jan 2013
Last update
Jul 13, 2016
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Taipei Medical University WanFang Hospital →

Start the discussion